Re: Emila (T DM1) Clinical Trial
My fiance is a new patient to this trial, in week 4, at Siteman Cancer Center in St. Louis, MO. It is starting to get very tough. She drew the 'Capecitabine and Lapatinib' regimen, which we believe was unfortunate considering the positive comments about the TDM-1. Thus far, we have dry skin, sore feet, blisters, diarrhea, numerous chancre sores, and now heavy chills. I welcome dialog with others in this study.
Bob (Kayakr01)
Last edited by Kayakr01; 08-15-2011 at 01:34 AM..
Reason: clarify post
|